Total Payments
$5,850
2024 Payments
$473.18
Companies
63
Transactions
322
Medicare Patients
4,296
Medicare Billing
$496,213
Payment Breakdown by Category
Food & Beverage$5,233 (89.4%)
Education$617.36 (10.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,233 | 298 | 89.4% |
| Education | $617.36 | 24 | 10.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $524.73 | 44 | $0 (2024) |
| Janssen Biotech, Inc. | $519.94 | 18 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $441.24 | 25 | $0 (2024) |
| Amgen Inc. | $328.19 | 12 | $0 (2023) |
| Seagen Inc. | $298.03 | 11 | $0 (2023) |
| Merck Sharp & Dohme LLC | $272.12 | 15 | $0 (2024) |
| Genentech USA, Inc. | $269.44 | 21 | $0 (2019) |
| Celgene Corporation | $247.25 | 12 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $244.93 | 15 | $0 (2019) |
| Seattle Genetics, Inc. | $212.13 | 11 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $473.18 | 22 | PFIZER INC. ($53.94) |
| 2023 | $774.34 | 29 | Seagen Inc. ($177.06) |
| 2022 | $360.83 | 17 | Seagen Inc. ($62.99) |
| 2021 | $174.32 | 13 | PFIZER INC. ($140.70) |
| 2020 | $379.24 | 25 | PFIZER INC. ($115.77) |
| 2019 | $1,269 | 70 | Amgen Inc. ($155.63) |
| 2018 | $1,230 | 78 | Janssen Biotech, Inc. ($173.92) |
| 2017 | $1,189 | 68 | Amgen Inc. ($120.30) |
All Payment Transactions
322 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Geron Corporation | RYTELO (Drug) | Food and Beverage | In-kind items and services | $26.92 | General |
| Category: MYELODYSPLASTIC SYNDROME | ||||||
| 12/12/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: Oncology | ||||||
| 12/10/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Education | In-kind items and services | $17.02 | General |
| Category: ONCOLOGY | ||||||
| 11/21/2024 | Deciphera Pharmaceuticals Inc. | QINLOCK (Drug), TGCT | Food and Beverage | In-kind items and services | $25.24 | General |
| Category: ONCOLOGY | ||||||
| 11/14/2024 | Stemline Therapeutics Inc. | Orserdu (Drug) | Food and Beverage | In-kind items and services | $22.28 | General |
| Category: Oncology | ||||||
| 07/18/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $29.02 | General |
| Category: Oncology | ||||||
| 07/11/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: Oncology | ||||||
| 06/07/2024 | Lilly USA, LLC | VERZENIO (Drug), JAYPIRCA | Food and Beverage | In-kind items and services | $27.70 | General |
| Category: Oncology | ||||||
| 05/17/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: Rare Disease | ||||||
| 05/02/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $28.63 | General |
| Category: ONCOLOGY | ||||||
| 04/05/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $22.53 | General |
| Category: Oncology | ||||||
| 03/28/2024 | PFIZER INC. | ELREXFIO (Drug) | Food and Beverage | In-kind items and services | $15.10 | General |
| Category: ONCOLOGY | ||||||
| 03/21/2024 | PFIZER INC. | INLYTA (Drug), XTANDI, TALZENNA | Food and Beverage | In-kind items and services | $18.23 | General |
| Category: ONCOLOGY | ||||||
| 03/04/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $24.88 | General |
| Category: Oncology | ||||||
| 02/29/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $24.95 | General |
| Category: ONCOLOGY | ||||||
| 02/17/2024 | PFIZER INC. | ELREXFIO (Drug), ADCETRIS | Food and Beverage | In-kind items and services | $20.61 | General |
| Category: ONCOLOGY | ||||||
| 02/15/2024 | Karyopharm Therapeutics Inc. | XPOVIO (Drug) | Food and Beverage | In-kind items and services | $18.22 | General |
| Category: Oncology | ||||||
| 02/08/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $16.29 | General |
| Category: Oncology | ||||||
| 02/01/2024 | SOBI, INC | DOPTELET (Drug) | Food and Beverage | In-kind items and services | $24.42 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 01/25/2024 | Ipsen Biopharmaceuticals, Inc | Onivyde (Drug) | Food and Beverage | In-kind items and services | $17.60 | General |
| Category: Oncology | ||||||
| 01/18/2024 | ARRAY BIOPHARMA INC | LORBRENA (Drug), BRAFTOVI, MEKTOVI | Food and Beverage | In-kind items and services | $18.25 | General |
| Category: ONCOLOGY | ||||||
| 01/04/2024 | GlaxoSmithKline, LLC. | OJJAARA (Drug) | Food and Beverage | In-kind items and services | $20.86 | General |
| Category: ONCOLOGY | ||||||
| 11/17/2023 | PFIZER INC. | ELREXFIO (Drug) | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: ONCOLOGY | ||||||
| 11/09/2023 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $26.09 | General |
| 10/19/2023 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $24.88 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 784 | 1,493 | $445,083 | $102,075 |
| 2022 | 9 | 743 | 1,401 | $324,013 | $95,103 |
| 2021 | 8 | 787 | 1,399 | $285,945 | $90,327 |
| 2020 | 27 | 1,982 | 27,311 | $887,803 | $208,708 |
Total Patients
4,296
Total Services
31,604
Medicare Billing
$496,213
Procedure Codes
52
All Medicare Procedures & Services
52 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 386 | 1,028 | $313,947 | $70,967 | 22.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 233 | 278 | $60,273 | $12,463 | 20.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 42 | 42 | $16,758 | $4,238 | 25.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 35 | 39 | $16,848 | $3,886 | 23.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 29 | 29 | $15,312 | $3,726 | 24.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 24 | 26 | $8,294 | $2,503 | 30.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 17 | 17 | $7,939 | $2,245 | 28.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 18 | 34 | $5,712 | $2,048 | 35.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 330 | 898 | $212,826 | $62,839 | 29.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 245 | 291 | $47,724 | $13,171 | 27.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 43 | 43 | $19,522 | $5,577 | 28.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 44 | 44 | $15,796 | $4,487 | 28.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 19 | 20 | $8,860 | $3,012 | 34.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 19 | 46 | $7,268 | $2,497 | 34.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 17 | 17 | $5,423 | $1,805 | 33.3% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 11 | 12 | $3,624 | $1,228 | 33.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 15 | 30 | $2,970 | $486.76 | 16.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 364 | 841 | $186,837 | $59,727 | 32.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 255 | 299 | $44,781 | $13,605 | 30.4% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 48 | 48 | $21,112 | $6,602 | 31.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 34 | 34 | $11,958 | $3,464 | 29.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 32 | 63 | $9,096 | $3,179 | 35.0% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 17 | 17 | $3,304 | $1,323 | 40.1% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 18 | 45 | $3,841 | $1,303 | 33.9% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 19 | 52 | $5,016 | $1,123 | 22.4% |
About Dr. Bradley Larson, MD
Dr. Bradley Larson, MD is a Hematology & Oncology healthcare provider based in Carrollton, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/13/2005. The National Provider Identifier (NPI) number assigned to this provider is 1194729582.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bradley Larson, MD has received a total of $5,850 in payments from pharmaceutical and medical device companies, with $473.18 received in 2024. These payments were reported across 322 transactions from 63 companies. The most common payment nature is "Food and Beverage" ($5,233).
As a Medicare-enrolled provider, Larson has provided services to 4,296 Medicare beneficiaries, totaling 31,604 services with total Medicare billing of $496,213. Data is available for 4 years (2020–2023), covering 52 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Carrollton, GA
- Active Since 06/13/2005
- Last Updated 12/13/2017
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1194729582
Products in Payments
- ADCETRIS (Biological) $270.57
- IBRANCE (Drug) $243.98
- KEYTRUDA (Biological) $235.82
- IMBRUVICA (Drug) $233.77
- TUKYSA (Drug) $181.62
- OPDIVO (Biological) $179.45
- JAKAFI (Drug) $158.24
- Kyprolis (Biological) $114.56
- ERLEADA (Drug) $99.95
- KISQALI (Drug) $99.32
- ZOLADEX (Drug) $99.18
- DARZALEX (Biological) $87.89
- PROMACTA (Drug) $87.42
- TASIGNA (Drug) $82.73
- Lonsurf (Drug) $80.23
- NINLARO (Drug) $73.48
- Revlimid (Drug) $72.55
- CALQUENCE (Drug) $72.14
- INJECTAFER (Drug) $68.72
- Nubeqa (Drug) $67.79
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Carrollton
Dr. Vibha Thomas, M.d, M.D
Hematology & Oncology — Payments: $19,445
Hematology & Oncology $19,445
Dr. Yuesheng Qu, M.d, M.D
Hematology & Oncology — Payments: $8,797
Hematology & Oncology $8,797
Dr. Randall Pierce, Md, MD
Hematology & Oncology — Payments: $6,978
Hematology & Oncology $6,978
Dr. Enrique Perez, Md, MD
Hematology & Oncology — Payments: $5,579
Hematology & Oncology $5,579